You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients—A One-Year Prospective Study
|
---|---|
Published in |
Therapeutic Drug Monitoring, April 2012
|
DOI | 10.1097/ftd.0b013e31824981a6 |
Pubmed ID | |
Authors |
Bhavik M. Patel, Jennifer Paratz, Natalie C. See, Michael J. Muller, Michael Rudd, David Paterson, Scott E. Briscoe, Jacobus Ungerer, Brett C. McWhinney, Jeffrey Lipman, Jason A. Roberts |
Abstract |
Beta-lactams are first-line antibiotics for the management of superficial infections due to burn injury. There is sparse data available on therapeutic drug monitoring (TDM) in patients with burns in a ward setting. This study was conducted to evaluate the utility of a beta-lactam TDM program in a cohort of burn injury patients in a ward environment. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 67% |
United States | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 67% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 4% |
France | 1 | 2% |
Australia | 1 | 2% |
Unknown | 49 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 11 | 21% |
Student > Ph. D. Student | 7 | 13% |
Researcher | 6 | 11% |
Student > Master | 6 | 11% |
Lecturer | 4 | 8% |
Other | 11 | 21% |
Unknown | 8 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 32% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 15% |
Agricultural and Biological Sciences | 3 | 6% |
Chemistry | 3 | 6% |
Immunology and Microbiology | 3 | 6% |
Other | 4 | 8% |
Unknown | 15 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2012.
All research outputs
#15,740,505
of 25,374,917 outputs
Outputs from Therapeutic Drug Monitoring
#895
of 1,787 outputs
Outputs of similar age
#103,177
of 173,050 outputs
Outputs of similar age from Therapeutic Drug Monitoring
#2
of 20 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,787 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,050 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.